Electrochemical characteristics of nitroheterocyclic compounds of biological interest. V. Measurement and comparison of nitro radical lifetimes
Using mixed aqueous/dimethylformamide solvents we have generated nitro radical anions by electrochemical reduction of nitroaromatic compounds. Six drugs have been examined: metronidazole, nitrofurazone, nifuroxime, chloramphenicol, M&B 4998 and 4(5)-nitroimidazole, chosen to represent a variety...
Saved in:
Published in: | International journal of radiation biology Vol. 57; no. 1; p. 45 |
---|---|
Main Authors: | , |
Format: | Journal Article |
Language: | English |
Published: |
England
01-01-1990
|
Subjects: | |
Online Access: | Get more information |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Using mixed aqueous/dimethylformamide solvents we have generated nitro radical anions by electrochemical reduction of nitroaromatic compounds. Six drugs have been examined: metronidazole, nitrofurazone, nifuroxime, chloramphenicol, M&B 4998 and 4(5)-nitroimidazole, chosen to represent a variety of ring structures and a range of reduction potentials. Analysis of the cyclic voltammetric response as a function of scan rate and dimethylformamide content yields information on the reactivity of RNO2.-. A kinetic analysis of the return-to-forward peak current ratio based on a theoretical treatment was employed. Second-order kinetics for the decay of RNO2.- for all six drugs examined was established. By extrapolation, first half-lives in purely aqueous media were found to increase in the order: nitrofurazone, nifuroxime, chloramphenicol, metronidazole and M&B 4998 (from 8.9 x 10(-2) seconds for nitrofurazone to 98s for M&B 4998 at a radical anion concentration of 1 x 10(-6) mol/dm3). Comparison with reduction potentials showed that as the lifetime of RNO2.- increased, the drug became progressively less electron-affinic (reduced at more negative potentials). The reactivity of RNO2.- was also examined in relation to the DNA damaging capability following electrochemical reduction of these nitroaromatic drugs. |
---|---|
ISSN: | 0955-3002 |
DOI: | 10.1080/09553009014550331 |